Tag Archives: Aeras

A TB vaccine? GHIT Fund eyes that prize, and more as public private partnership takes off

By on .

What does it take to move research from recognition of need to realization? Increasingly, in a funding landscape that has seen an actual decline in dollars to develop new tools for tuberculosis along with other diseases, the answer has been public-private partnerships. The most recent prominent example is the Global Health Innovative Technology — GHIT […]

With TB research threatened, doctors, patients, advocates and filmmakers spell out risks

By on .

At a recent conference of medical researchers, National Institute of Allergy and Infectious Diseases Director Anthony Fauci spelled out what lawmakers appear to be missing in their budget balancing efforts. “They don’t realize,” Fauci said, “that hitting biomedical research now is going to have an impact, three, four years from now.” So efforts to let […]

TB Week: Integration, involvement, a “holistic” approach key to linking women and tuberculosis care

By on .

When a week of events focusing on the worldwide impact of tuberculosis brings together a group to talk about women’s health and diplomacy, it needs to be a broad-based group, and it was. For a start, the talk at the Washington Club in Washington, DC was sponsored by The Center for Global Health and Diplomacy, […]

TB vaccine trial: “A stepping stone on a very long journey”

By on .

In the wake of announcing clinical trial results that showed  a candidate for a tuberculosis vaccine was safe, but did not protect babies from infection and disease, researchers are emphasizing what they have learned, and how it might yet pave the way for a long-term answer to the epidemic. The trial of MVA85A, a candidate […]

Aren’t These Lives Worth Saving, Too?

By on .

This is a guest blog jointly submitted by Jerald C. Sadoff, MD, the President & Chief Executive Officer of the Aeras Global TB Vaccine Foundation and Mel Spigelman, MD, the President & Chief Executive Officer of the Global Alliance for TB Drug Development. In recent weeks, U.S.-based global health advocates have been scrutinizing and providing […]